Articles From: Ipsen Biopharmaceuticals, Inc. Announces Key Medical and Commercial Hires to IRIDEX to Present at 2014 Wedbush Life Sciences Management Access Conference


2014/9/10
Ipsen Biopharmaceuticals, Inc. , an affiliate of Ipsen (Euronext: IPN; ADR: IPSEY), today announced key hires as the company continues to build its executive management capabilities.
Sign-up for Ipsen Biopharmaceuticals, Inc. Announces Key Medical and Commercial Hires investment picks
Ipsen Biopharmaceuticals, Inc., the U.S. affiliate of Ipsen (Euronext: IPN; ADR: IPSEY) today announced that it has submitted a Supplemental New Drug Application to the U.S. Food and Drug Administration (FDA) for Somatuline ® Depot 120mg injection for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs). In the European Union, Ipsen has submitted national marketing authorization variations for Somatuline ® Autogel ® 120mg injection to the drug regulatory authorities in 25 countries.
Sign-up for Ipsen submits marketing authorization applications in the U.S. and Europe for Somatuline® (lanreotide) in the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) investment picks
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that it has submitted a Supplemental New Drug Application to the U.S. Food and Drug Administration (FDA) for Somatuline ® Depot 120mg injection for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs). In the European Union, Ipsen has submitted national marketing authorization variations for Somatuline ® Autogel ® 120mg injection to the drug regulatory authorities in 25 countries of the European Union.
Sign-up for Ipsen submits marketing authorization applications in the US and Europe for Somatuline® (lanreotide) in the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) investment picks
2014/8/29
Regualtory News: The Board of Directors of Ipsen (Euronext: IPN; ADR: IPSEY), chaired by Marc de Garidel, met on 28 August 2014 to approve the financial statements for the first half 2014, published today.
Sign-up for Ipsen: 2014 Half-Year Results and 2014 Objectives investment picks
ULR Contracts on Stored Value Card Technology Owned by JPMorgan Chase Bank, N.A. CHICAGO , July 21, 2014 /PRNewswire/ -- Intellectual Property Exchange International, Inc. (IPXI), the world's first financial exchange for licensing and trading intellectual property (IP) rights, announced that on Friday it successfully closed its first two initial offerings of unit license rights.
Sign-up for IPXI® Prices First Offerings; Intellectual Property Market Opens for Trading investment picks
International Rectifier, IR ® (NYSE: IRF), a world leader in power management technology, today announced the expansion of its portfolio of 60V StrongIRFET™ power MOSFETs available in various standard and performance power packages.
Sign-up for IR Expands Portfolio of 60V StrongIRFET™ MOSFETs Featuring Ultra-low Rds(on) in Standard and Performance Power Packages for Industrial Applications investment picks
International Rectifier, IR ® (NYSE: IRF), a world leader in power management technology, today announced the introduction of the D Series of low power radiation-tolerant two output DC-DC converters developed to meet the high reliability design needs of satellite power systems.
Sign-up for IR Introduces D Series of Low Power High Reliability Two Output DC-DC Converters for Satellite Power Systems investment picks
International Rectifier, IR ® (NYSE: IRF), a world leader in power management technology, today announced the introduction of the IR66xx series of high performance 600V ultra-fast Trench-gate Field Stop insulated-gate bipolar transistors (IGBTs). The new rugged, reliable family of devices features extremely low conduction and switching losses optimized for welding applications.
Sign-up for IR Introduces IR66xx Series of High Performance 600V Ultra-fast Trench IGBTs Optimized for Welding Applications investment picks
International Rectifier, IR ® (NYSE: IRF), a world leader in power management technology, today announced the introduction of the M3G120 Series of 40W radiation-hardened (RAD-Hard) 120V input DC-DC converters for a wide range of digital and analog satellite power systems requiring up to 15 years or more of mission life such as space stations and NASA’s Orion MPCV (Multi-Purpose Crew Vehicle) programs.
Sign-up for IR Introduces M3G120 Series of 40W Radiation-Hardened 120V Input DC-DC Converters for Satellite Power Systems investment picks
International Rectifier, IR ® (NYSE:IRF), a world leader in power management technology, today introduced the automotive-qualified AUIRB24427S high current dual low-side driver IC for Switched Mode Power Supply (SMPS) applications used in Hybrid Electrical Vehicles (HEV), Electric Vehicles (EV), and high power industrial converters.
Sign-up for IR Introduces Robust Automotive-Qualified AUIRB24427S Dual Low-side Driver IC for Switched Mode Power Supply (SMPS) Applications investment picks
International Rectifier, IR ® (NYSE: IRF), a world leader in power management technology, today announced the introduction of the automotive-qualified AUIRFN8403 COOLiRFET™ power MOSFET for automotive applications that require compact size and high current performance including pump motor control and automotive body control.
Sign-up for IR’s Automotive-Qualified AUIRFN8403 in Compact PQFN 5X6 Delivers High Efficiency, High Power Density while Reducing Overall System Cost investment picks
International Rectifier, IR ® (NYSE: IRF), a world leader in power management technology, today announced that the company’s Generation 8 (Gen8) 1200V Insulated Gate Bipolar Transistor (IGBT) technology platform and IR3847 SupIRBuck ® high current integrated voltage regulator have been named winners of the prestigious 2014 China Annual Creativity in Electronics (ACE) Awards.
Sign-up for IR’s Gen8 IGBT Technology Platform and IR3847 SupIRBuck® Named 2014 China ACE Awards Winners investment picks
International Rectifier, IR ® (NYSE: IRF), a world leader in power management technology, today announced the expansion of the power block family of devices with the introduction of the IRFHE4250D FastIRFET™ dual power MOSFET that reduces power losses by more than 5% at 25A compared to best-in-class conventional power block devices.
Sign-up for IR’s IRFHE4250D FastIRFET™ 6x6 PQFN Power Block Featuring Exposed Top Delivers Superior Efficiency for DC-DC Applications investment picks
2010/02/22
The best and worst candidates for this maneuver, and details on how it works.
Sign-up for IRA Conversion Fact Sheet investment picks
2011/02/15
We highlight the best and worst candidates for this maneuver, and details on how it works.
Sign-up for IRA Conversion Fact Sheet investment picks
2009/08/27
Low investment balances, relaxed income limits make it worthy of consideration.
Sign-up for IRA Conversion: The Planning Opportunity of the Decade? investment picks
IRADIMED CORPORATION (NASDAQ:IRMD), the leading provider of non-magnetic intravenous (IV) infusion pump systems that are safe for use during magnetic resonance imaging (MRI) procedures, announced that it has closed its initial public offering of 2,318,400 shares of common stock at a price of $6.25 per share, including 302,400 shares sold pursuant to the over-allotment option exercised in full by the underwriters of the initial public offering.
Sign-up for IRADIMED CORPORATION Announces Closing of Initial Public Offering investment picks
WINTER SPRINGS, Fla., Sept.
Sign-up for IRADIMED CORPORATION Announces Conference Call to Discuss the Status of the Recent FDA Warning Letter investment picks
IRADIMED CORPORATION (NASDAQ:IRMD), the leading provider of non-magnetic intravenous (IV) infusion pump systems that are safe for use during magnetic resonance imaging (MRI) procedures, announced today the pricing of its initial public offering of 2,016,000 shares of its common stock at an initial public offering price of $6.25 per share for a total offering amount of $12.6 million before deducting underwriting discounts and commissions, and estimated offering expenses payable by Iradimed.
Sign-up for IRadimed Corporation Announces Pricing of Initial Public Offering investment picks
WINTER SPRINGS, Fla., Sept.
Sign-up for IRADIMED CORPORATION Announces Receipt of FDA Warning Letter investment picks
Reports revenue growth of 69% year-over-year Reports non-GAAP diluted EPS of $0.13, a 79% increase over last year Issues full year 2014 revenue guidance of $18.0 million to $18.2 million Closes on IPO and completes move into new facility WINTER SPRINGS, Fla., Aug.
Sign-up for IRADIMED CORPORATION Announces Second Quarter 2014 Financial Results investment picks
WINTER SPRINGS, Fla., Aug.
Sign-up for IRADIMED CORPORATION to Hold 2014 Second Quarter Financial Results Conference Call on August 12th investment picks
2014/9/15
Former United States Securities and Exchange Commission attorney Willie Briscoe , founder of The Briscoe Law Firm, PLLC , and the securities litigation firm of Powers Taylor LLP announce that a federal class action lawsuit has been filed against IRadimed Corporation (“IRadimed” or “Company”) (NasdaqCM: IRMD) and several officers and directors for acts taken during the period of July 15, 2014 to September 2, 2014 (the “Class Period”). Based upon the allegations in the class action, the firms are investigating additional legal claims against the officers and Board of Directors of IRadimed.
Sign-up for IRadimed Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0962094001&sourceType=1 http://www.ccnmatthews.com/logos1/ird.gif SASKATOON, SASKATCHEWAN --
Sign-up for IRD Awarded $3.4 Million Maintenance & Service Contract in Chile investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0954407001&sourceType=1 http://www.ccnmatthews.com/logos1/ird.gif SASKATOON, SASKATCHEWAN --
Sign-up for IRD Awarded CAD $5.1 Million Contract by California Department of Transportation investment picks
Ireland Inc. ( OTCBB: IRLD ) today announced that the Company will host an investor update conference call on Thursday, August 14, 2014 at 1:30 p.m. PDT (4:30 p.m. EDT). The purpose of this call is to update investors regarding the progress and developments related to the gold and silver extraction process at the Columbus Project and its on-site pilot plant located in Nevada.
Sign-up for Ireland Inc. to Host Q2 Results Conference Call on Thursday, August 14, 2014 investment picks
MOUNTAIN VIEW, Calif.
Sign-up for IRIDEX Announces Second Quarter 2014 Conference Call and Release Date investment picks
Revenue Up 15% Year over Year for Both Periods Board of Directors Establishes New Share Repurchase Program MOUNTAIN VIEW, Calif.
Sign-up for IRIDEX Reports 2014 Second Quarter, Six-Month Results investment picks
MOUNTAIN VIEW, Calif.
Sign-up for IRIDEX to Present at 2014 Wedbush Life Sciences Management Access Conference investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Ipsen Biopharmaceuticals, Inc. Announces Key Medical and Commercial Hires to IRIDEX to Present at 2014 Wedbush Life Sciences Management Access Conference
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices